News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

On the left side of the graphic is a caucasian man wearing glasses and a suit. The photo shows him in portrait mode. The right side is blue and has a white logo and text.
News Release

Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.

Read More
A logo on white background
News Release

INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.

Read More
Doctor putting a protector on child's arm after vaccination
Media Coverage

America’s vaccine system faces more than a crisis of public confidence. It faces a potential operational breakdown. Changing vaccine recommendations without accounting for manufacturing capacity, supply chains, distribution networks and patient access risks turning uncertainty into shortages, delays and declining vaccination rates.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Sheldon Jacobson: Effective Treatments, Not Vaccines, are Light at End of COVID-19 Tunnel

Sheldon Jacobson: Effective Treatments, Not Vaccines, are Light at End of COVID-19 Tunnel

Trib Live, December 12, 2020

We are nine months into the covid-19 pandemic, with many succumbing to face covering and physical distancing fatigue, and pockets of pervasive skepticism about the virus threat and its risk. No one is happy, and everyone has someone to blame for their anger, grief and malcontent. The question people are asking is, when will the pandemic end so we can stop wearing face coverings and physically distance?

Social Advertising Effectiveness In Specific Product Categories

Social Advertising Effectiveness In Specific Product Categories

Weekly Technology Times, December 11, 2020

New research from a team of scientists at four leading universities has shed new light on the effectiveness of social advertising in specific product categories to learn which product categories tend to benefit more from social advertising, and which may not. “Social advertising is the placement of social cues or endorsements in ads shown to friends of those who have engaged with a brand or product,” said Huang. “Some examples include Facebook’s social advertising that places the images and names of Facebook friends who have liked a brand in their ads. 

A Vaccine Is Coming Soon, but Questions Remain for Rural America

A Vaccine Is Coming Soon, but Questions Remain for Rural America

US News, December 10, 2020

A Food and Drug Administration advisory committee was meeting Thursday to discuss whether the agency should grant emergency use authorization for Pfizer Inc.'s coronavirus vaccine candidate. Later this month, members will meet on a vaccine from Moderna. In short, a vaccine is likely to be on its way to specific members of the public very soon.

Vaccine Delivery Across the Country Faces Complex Supply Chain Challeneges

Vaccine Delivery Across the Country Faces Complex Supply Chain Challeneges

Marketplace, December 10, 2020

The nation’s first COVID-19 vaccine stands on the verge of approval, yet the complex distribution of the product — and the risk along the way — is keeping some logistics and public health professionals up at night. The stakes could not be higher. This vaccine represents what one freight industry executive has termed “the biggest product launch in history.” Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.

How Pfizer Plans to Distribute Millions of Vaccines at Ultra-Cold Temperatures

How Pfizer Plans to Distribute Millions of Vaccines at Ultra-Cold Temperatures

KCBS Radio, December 11, 2020

Pfizer’s coronavirus vaccine is all but assured to become the first in the U.S. to win an emergency use authorization after an FDA panel voted to recommend the vaccine for widespread use. The company’s vaccine needs to be stored at ultra-low temperatures, which will require special freezers and shipping methods in order to ensure the vaccine remains potent.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine